These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 2956040)
1. A comparison of semisynthetic human NPH insulin and porcine NPH insulin in the treatment of insulin-dependent diabetes mellitus. Pedersen C; Høegholm A Diabet Med; 1987; 4(4):304-6. PubMed ID: 2956040 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals. Sailer D; Ludwig T; Kolb S Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542 [TBL] [Abstract][Full Text] [Related]
3. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810 [TBL] [Abstract][Full Text] [Related]
4. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group. Rosenstock J; Park G; Zimmerman J; Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511 [TBL] [Abstract][Full Text] [Related]
5. Human (recombinant DNA) and porcine NPH insulins are unequally effective in diabetic patients. A comparative study using continuous blood glucose monitoring. Richard JL; Rodier M; Cavalié G; Mirouze J; Monnier L Acta Diabetol Lat; 1984; 21(3):211-7. PubMed ID: 6393670 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of NPH human insulin (recombinant DNA) and pork insulin in diabetic subjects: preliminary report. Mirouze J; Monnier L; Richard JL; Gancel A; Soua KB Diabetes Care; 1982; 5 Suppl 2():60-2. PubMed ID: 6765543 [TBL] [Abstract][Full Text] [Related]
7. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study. Beyer J; Enzmann F; Lauerbach M; Althoff P; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Haas R Diabetes Care; 1982; 5 Suppl 2():140-8. PubMed ID: 6765526 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of NPH human insulin (recombinant DNA) and NPH bovine insulin in diabetic subjects. Marre M; Tabbi-Anneni A; Tabbi-Anneni H; Assan R Diabetes Care; 1982; 5 Suppl 2():63-6. PubMed ID: 6765544 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of the effects of protamine-bound NPH porcine insulin and NPH human insulin in type 1 and 2 diabetes]. Renner R; Vocke K; Hepp KD Dtsch Med Wochenschr; 1986 Aug; 111(35):1316-20. PubMed ID: 3743441 [TBL] [Abstract][Full Text] [Related]
10. Optimal provision of daytime NPH insulin in patients using the insulin analog lispro. Ahmed AB; Home PD Diabetes Care; 1998 Oct; 21(10):1707-13. PubMed ID: 9773735 [TBL] [Abstract][Full Text] [Related]
11. Double-blind crossover trial of isophane (NPH)- and lente-based insulin regimens. Tunbridge FK; Newens A; Home PD; Davis SN; Murphy M; Burrin JM; Alberti KG; Jensen I Diabetes Care; 1989 Feb; 12(2):115-9. PubMed ID: 2649324 [TBL] [Abstract][Full Text] [Related]
12. [Insulin glargine improves fasting blood glucose levels in prepubertal children with unsatisfactorily controlled type 1 diabetes]. Mianowska B; Szadkowska A; Czerniawska E; Pietrzak I; Bodalski J Pediatr Endocrinol Diabetes Metab; 2007; 13(4):189-93. PubMed ID: 18042313 [TBL] [Abstract][Full Text] [Related]
13. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290 [TBL] [Abstract][Full Text] [Related]
14. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Heise T; Nosek L; Rønn BB; Endahl L; Heinemann L; Kapitza C; Draeger E Diabetes; 2004 Jun; 53(6):1614-20. PubMed ID: 15161770 [TBL] [Abstract][Full Text] [Related]
15. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro. Ahmed AB; Mallias J; Home PD Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. Hermansen K; Madsbad S; Perrild H; Kristensen A; Axelsen M Diabetes Care; 2001 Feb; 24(2):296-301. PubMed ID: 11213882 [TBL] [Abstract][Full Text] [Related]
17. Crossover study with human insulin (recombinant DNA) in type I diabetic subjects. Landgraf R; Kammerer S; Bock T; Smolka B; Ladik T; Enzmann F; Landgraf-Leurs MM Diabetes Care; 1982; 5 Suppl 2():39-42. PubMed ID: 6765538 [TBL] [Abstract][Full Text] [Related]
18. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin. Olsson PO; Hans A; Henning VS Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898 [TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan. Nor Azlin MI; Adam R; Sufian SS; Wahab NA; Mustafa N; Kamaruddin NA; Jamil MA J Obstet Gynaecol Res; 2011 Feb; 37(2):132-7. PubMed ID: 21159037 [TBL] [Abstract][Full Text] [Related]
20. Comparison of fixed-ratio versus variable-ratio regular and NPH semisynthetic human insulin in insulin-requiring diabetic patients. Khachadurian AK; Davidson JA; Braunstein S; Redmond G; Greenfield M; Lauritano AA; Haycock P Clin Ther; 1989; 11(4):485-94. PubMed ID: 2673516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]